Guobang Pharmaceutical

Company Deals

ZSCO Invests 790 m RMB in Guobang Pharma, Launches Strategic Partnership

Fineline Cube Sep 15, 2025

Zhejiang State‑owned Capital Operation Co., Ltd. (ZSCO) and Guobang Pharmaceutical (SHA: 605507) announced a strategic...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod